Impact of letrozole co-treatment in an antagonist protocol for IVF/ICSI: a retrospective study
Our findings suggested that letrozole co-treatment in antagonist protocol for IVF/ICSI was associated with a comparable live birth rate following fresh ET. Further prospective randomized studies are needed to verify our results.
Authors
- Jiaying Lin (ORCID: https://orcid.org/0000-0002-1473-5636)
- Bian Wang (ORCID: https://orcid.org/0000-0001-8489-2744)
- Jing Lin (ORCID: https://orcid.org/0000-0001-6272-1039)
- Qianqian Zhu (ORCID: https://orcid.org/0000-0002-5787-0985)
- Fenglu Wu
Institutions
- Shanghai Jiao Tong University (CN)
- XinHua Hospital (CN)
- Shanghai Ninth People's Hospital (CN)
Publication Details
- Journal
- Reproductive Biology and Endocrinology
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1186/s12958-024-01297-5
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China